Camp4 Therapeutics (CAMP) Income towards Parent Company: 2023-2025
Historic Income towards Parent Company for Camp4 Therapeutics (CAMP) over the last 2 years, with Sep 2025 value amounting to -$13.2 million.
- Camp4 Therapeutics' Income towards Parent Company rose 1.90% to -$13.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$51.6 million, marking a year-over-year decrease of 0.41%. This contributed to the annual value of -$51.8 million for FY2024, which is 5.07% down from last year.
- As of Q3 2025, Camp4 Therapeutics' Income towards Parent Company stood at -$13.2 million, which was down 5.19% from -$12.6 million recorded in Q2 2025.
- Camp4 Therapeutics' Income towards Parent Company's 5-year high stood at -$11.7 million during Q3 2023, with a 5-year trough of -$13.5 million in Q3 2024.
- Over the past 3 years, Camp4 Therapeutics' median Income towards Parent Company value was -$12.6 million (recorded in 2025), while the average stood at -$12.7 million.
- As far as peak fluctuations go, Camp4 Therapeutics' Income towards Parent Company decreased by 15.29% in 2024, and later rose by 1.90% in 2025.
- Camp4 Therapeutics' Income towards Parent Company (Quarterly) stood at -$13.0 million in 2023, then fell by 2.22% to -$13.3 million in 2024, then increased by 1.90% to -$13.2 million in 2025.
- Its last three reported values are -$13.2 million in Q3 2025, -$12.6 million for Q2 2025, and -$12.5 million during Q1 2025.